+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brucellosis. The Silent Threat to Livestock and Human Health

  • Book

  • October 2025
  • Elsevier Science and Technology
  • ID: 6249749

Brucellosis: The Silent Threat to Livestock and Human Health offers an in-depth look into the challenges posed by brucellosis, including its prevention, control, diagnosis, and treatment in animals and humans. This zoonotic disease is a significant concern not only for animal health but also public health, creating an economic burden worldwide. As the first comprehensive reference on brucellosis in decades, this book provides valuable insights into combating and managing the disease in herds and communities. The book emphasizes the importance of the One Health approach, presenting a global perspective on brucellosis.

In addition, it discusses the contagious nature of the disease and its impact on livestock and humans, particularly those working in animal husbandry. The book serves as a foundation for new research, highlighting the need for further studies due to the lack of a cure for animals and the difficulties in treating humans.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Historical context and background of
brucellosis in the world
2. Brucellosis throughout human history
3. The genetic diversity of Brucella species
Part II Pathogenesis and immunobiology of brucellosis
4. Pathogenesis and immunopathological phenomena around Brucella infections

5. Immunopathology in osteoarticular Brucella infection

Part III
Brucellosis in animals
6. Brucellosis in livestock and companion animals
7. Brucellosis in dogs: epidemiology, diagnosis, and public health concerns
8. Brucellosis in aquatic mammals

Part IV
Zoonotic transmission
10. Occupational exposure to Brucella spp. and risk behaviors in exposed professions
11. Brucellosis in Tanzania and Rwanda: Current status, challenges, and control strategies

Part V Diagnostic tools and techniques
12. Diagnostic tools and techniques for Brucella detection
13. Pathology of brucellosis in livestock

Part VI Clinical manifestations in humans
14. Brucellosis: Clinical manifestations in humans
15. Rare cases of human brucellosis
Part VII Prevention and control in animals
16. The science of brucellosis elimination

17. Brucellosis control, eradication, and prevention

18. Comprehensive strategies for brucellosis control in endemic areas
19. Efficacy of Brucella vaccine strains: S19, RB51, and Rev-1
Part VIII Prevention and control in humans
20. Therapeutic advances in human brucellosis
21. Medicinal plants used in the treatment of brucellosis
Part IX One health approach
22. Knowledge, attitudes, and practices (KAP) relating to brucellosis: Unveiling the vital role of public awareness
23. One health approach to brucellosis in SE Europe

Part X Emerging trends and future prospects
24. Challenges posed by antibiotic resistance in human and animal brucellosis
25. Antimicrobial resistance of Brucella melitensis

Part XI Brucellosis in food safety and processing
26. Brucellosis in food safety

Authors

Maryam Dadar Researcher, Department of Brucellosis at the Razi Vaccine and Serum Research Institute, Karaj, IranIran.

Maryam Dadar, DVM, PhD, is currently a researcher at the Veterinary Council of Iran, Tehran, Iran. She s an Assistant Professor in the Department of Brucellosis at the Razi Vaccine and Serum Research Institute in Iran. Her extensive expertise lies in the field of microbiology and molecular biology, with main areas of research in zoonotic diseases, microbial risk assessments, Brucellosis prevention and control, and One Health. She has published articles in numerous international journals, edited books including an Elsevier title on brucellosis, and serves as an editor and is on the editorial board of a number of journals such as Microbial Risk Analysis (Elsevier). Dr. Dadar actively participates in international, multidisciplinary research collaborations with colleagues in Germany, United Kingdom, United States, and Pakistan and in educational initiatives aimed at advancing the scientific foundations of zoonotic infections, veterinary science, and molecular medicine.